Concepedia

Yamila B. Gándola

YB

Statistics

Publications

8

Citations

286

H-Index

8

Active since

2012

Affiliations

Consejo Nacional de Investigaciones Científicas y Técnicas(Current)

Instituto de Química y Fisicoquímica Biológicas

Universidad de Buenos Aires

Instituto de Biotecnología y Biología Molecular

Hospital César Milstein

Yamila B. Gándola is an author at Consejo Nacional de Investigaciones Científicas y Técnicas specializing in drug delivery, pharmacy, and nanoparticle drug delivery.

ORCID

Publications per year

2012–2022

8

Publications

8

Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells

Claudia R. Arbeitman, Gabriela Auge, Matı́as Blaustein et al. · Scientific Reports · 2020 · 130 citations · Full text

, , +16

Mitogenic Effects of Phosphatidylcholine Nanoparticles on MCF-7 Breast Cancer Cells

Yamila B. Gándola, Sebastián E. Pérez, Pablo E Irene et al. · BioMed Research International · 2014 · 39 citations · Full text

, , +17

Development, Characterization, and In Vitro Evaluation of Tamoxifen Microemulsions

Ezequiel Monteagudo, Yamila B. Gándola, Lorena González et al. · Journal of Drug Delivery · 2012 · 29 citations · Full text

, , +17

Validation of commercial Mas receptor antibodies for utilization in Western Blotting, immunofluorescence and immunohistochemistry studies

Valeria Burghi, Natalia Cristina Fernández, Yamila B. Gándola et al. · PLoS ONE · 2017 · 23 citations · Full text

, , +16

Covalent coupling of Spike’s receptor binding domain to a multimeric carrier produces a high immune response against SARS-CoV-2

Paula M. Berguer, Matı́as Blaustein, Luis M. Bredeston et al. · Scientific Reports · 2022 · 19 citations · Full text

, , +17

1–5 of 8